CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

NCT04387071 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study drug no longer available

Conditions

Locally Advanced Malignant Solid Neoplasm
Metastatic Pancreatic Adenocarcinoma
Stage IV Pancreatic Cancer AJCC v8
Unresectable Malignant Solid Neoplasm

Interventions

BIOLOGICAL: Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
DRUG: VLP-encapsulated TLR9 Agonist CMP-001

Sponsor

University of Southern California

Collaborators

[object Object]